Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.9999
-0.0001 (-0.01%)
At close: Nov 13, 2026, 4:00 PM EST
0.9900
-0.0099 (-0.99%)
After-hours: Nov 13, 2026, 7:59 PM EST

Spero Therapeutics Stock Forecast

SPRO's stock price has decreased by -62.41% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, Spero Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.33. The average 1-year stock price forecast is 433.35% higher than the current stock price, while the lowest is $4.00 (+300.04%) and the highest is $6.00 (+500.06%).

Price Target: $5.33 (+433.35%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.00$5.33$6.00$6.00
Change+300.04%+433.35%+500.06%+500.06%

Analyst Ratings

The average analyst rating for Spero Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingDec '25Mar '26Jun '26Sep '26Oct '26Nov '26
Strong Buy000122
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total111233

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$6
BuyInitiates$6+500.06%Oct 29, 2026

Financial Forecast

Revenue This Year
300.00K
from 66.80M
Decreased by -99.55%
Revenue Next Year
n/a
from 300.00K
Decreased by -100.00%
EPS This Year
-1.28
EPS Next Year
-0.98
from -1.28
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
18.26M53.51M103.78M47.98M66.80M300.00K
Revenue Growth
95.67%193.10%93.95%-53.77%39.24%-99.55%
Operating Income
-87.97M-30.57M26.79M-72.48M7.16M-67.80M
Net Income
-89.76M-46.42M22.81M-68.57M8.57M-33.46M
EPS
------1.28
Free Cash Flow
------22.70M
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High300,000
Avg300,000
Low300,000

Revenue Growth

Revenue Growth202620272028
High
-99.6%
Avg
-99.6%
Low
-99.6%

EPS Forecast

EPS202620272028
High-1.28
Avg-1.28
Low-1.28

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-